ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,035.69
-1.57%
US Tech 100
16,940.00
-2.14%
다우존스 지수
37,815.92
-1.49%
Bitcoin
59,976.10
-6.05%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Kiniksa Pharmaceuticals Ltd (KNSA)

  7. Kiniksa Pharmaceuticals Ltd (KNSA) 뉴스

KNSA Kiniksa Pharmaceuticals Ltd

18.72
0.17 (0.92%)
시간외 거래
최종 업데이트: 05:01:41
15분 지연
기업명 주식 심볼 시장 주식 타입
Kiniksa Pharmaceuticals Ltd KNSA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.17 0.92% 18.72 05:01:41
개장가 저가 고가 종가 전일 종가
18.49 18.2598 18.84 18.72 18.55
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202420:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2024 Financial..
17/04/202405:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2024..
02/04/202420:30GLOBEKiniksa Pharmaceuticals Announces Development Indication for..
06/03/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:29EDGAR2Form 144 - Report of proposed sale of securities
01/03/202406:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202421:35EDGAR2Form 8-K - Current report
28/02/202421:30GLOBEKiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year..
28/02/202407:06EDGAR2Form 144 - Report of proposed sale of securities
22/02/202406:01GLOBEKiniksa Pharmaceuticals to Report Fourth Quarter and..
15/02/202406:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202405:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202421:37EDGAR2Form 8-K - Current report
04/01/202421:30GLOBEKiniksa Pharmaceuticals Provides Corporate Update
04/01/202406:55EDGAR2Form 144 - Report of proposed sale of securities
03/01/202406:01GLOBEKiniksa Pharmaceuticals to Present at 42nd Annual J.P...
12/12/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202306:46EDGAR2Form 144 - Report of proposed sale of securities
03/11/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202320:35EDGAR2Form 8-K - Current report
31/10/202320:30GLOBEKiniksa Pharmaceuticals Reports Third Quarter 2023 Financial..
25/10/202305:01GLOBEKiniksa Pharmaceuticals to Report Third Quarter 2023..
07/09/202308:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202308:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202308:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202306:26EDGAR2Form 144 - Report of proposed sale of securities
19/08/202305:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/08/202305:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/08/202305:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/07/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/07/202306:14EDGAR2Form 144 - Report of proposed sale of securities
25/07/202320:40EDGAR2Form 8-K - Current report
25/07/202320:30GLOBEKiniksa Pharmaceuticals Reports Second Quarter 2023..
17/07/202321:00GLOBEKiniksa Pharmaceuticals to Report Second Quarter 2023..
07/06/202305:01GLOBEKiniksa Pharmaceuticals to Present at Goldman Sachs 44th..
02/05/202320:30GLOBEKiniksa Pharmaceuticals Reports First Quarter 2023 Financial..
02/05/202305:01GLOBEKiniksa Pharmaceuticals to Report First Quarter 2023..

최근 히스토리

NASDAQ
KNSA
Kiniksa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유